PeptideDB

CAY10499 359714-55-9

CAY10499 359714-55-9

CAS No.: 359714-55-9

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor (antagonist) with IC50s for recombinant human monoacylglycerol
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

MAGL-IN-5 (CAY10499) is a non-selective lipase inhibitor (antagonist) with IC50s for recombinant human monoacylglycerol lipase (MAGL), hormone-sensitive lipase (HSL) and fatty acid amide hydrolase (FAAH). 144, 90 and 14 nM respectively.

Physicochemical Properties


Molecular Formula C18H17N3O5
Molecular Weight 355.35
Exact Mass 355.116
CAS # 359714-55-9
PubChem CID 9924775
Appearance Off-white to yellow solid powder
Density 1.3±0.1 g/cm3
Index of Refraction 1.610
LogP 1.97
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 6
Heavy Atom Count 26
Complexity 547
Defined Atom Stereocenter Count 0
InChi Key QTENHWTVRQKWRI-UHFFFAOYSA-N
InChi Code

InChI=1S/C18H17N3O5/c1-12-10-14(21-18(23)26-17(20-21)24-2)8-9-15(12)19-16(22)25-11-13-6-4-3-5-7-13/h3-10H,11H2,1-2H3,(H,19,22)
Chemical Name

benzyl N-[4-(5-methoxy-2-oxo-1,3,4-oxadiazol-3-yl)-2-methylphenyl]carbamate
Synonyms

CAY 10499; CAY-10499; CAY10499
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: This product requires protection from light (avoid light exposure) during transportation and storage.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay. Chembiochem. 2008 Nov 3;9(16):2704-10.

[2]. 4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors. J Enzyme Inhib Med Chem. 2016;31(1):137-46.

Additional Infomation CAY10499 is a carbamate ester.

Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~281.42 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (7.04 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (7.04 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.8141 mL 14.0706 mL 28.1413 mL
5 mM 0.5628 mL 2.8141 mL 5.6283 mL
10 mM 0.2814 mL 1.4071 mL 2.8141 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.